Bioxcel Therapeutics Stock Price History
| BTAI Stock | USD 1.91 0.03 1.55% |
Below is the normalized historical share price chart for BioXcel Therapeutics extending back to March 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioXcel Therapeutics stands at 1.91, as last reported on the 19th of July, with the highest price reaching 2.00 and the lowest price hitting 1.87 during the day.
If you're considering investing in BioXcel Stock, it is important to understand the factors that can impact its price. BioXcel Therapeutics appears to be slightly risky, given 3 months investment horizon. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0584, which signifies that the company had a 0.0584 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioXcel Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of BioXcel Therapeutics' Downside Deviation of 5.11, risk adjusted performance of 0.0345, and Mean Deviation of 4.32 to double-check if our risk estimates are consistent with your expectations. As of now, BioXcel Therapeutics' Common Stock is increasing as compared to previous years. The BioXcel Therapeutics' current Stock Based Compensation is estimated to increase to about 10.3 M, while Total Stockholder Equity is forecasted to increase to (88.4 M). . The current Price To Sales Ratio is estimated to decrease to 6.36. The current Price Earnings Ratio is estimated to decrease to -0.27. BioXcel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 2018 | 200 Day MA 4.4832 | 50 Day MA 1.6737 | Beta (0.13) |
Sharpe Ratio = 0.0584
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BTAI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.21 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average BioXcel Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioXcel Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.9656 | Enterprise Value Ebitda (0.75) | Price Sales 6.2457 | Shares Float 5.5 M | Wall Street Target Price 23.25 |
BioXcel Therapeutics Stock Price History Chart
There are several ways to analyze BioXcel Stock price data. The simplest method is using a basic BioXcel candlestick price chart, which shows BioXcel Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 25, 2025 | 2.05 |
| Lowest Price | May 30, 2025 | 1.18 |
BioXcel Therapeutics July 19, 2025 Stock Price Synopsis
Various analyses of BioXcel Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioXcel Stock. It can be used to describe the percentage change in the price of BioXcel Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioXcel Stock.| BioXcel Therapeutics Accumulation Distribution | 11,460 | |
| BioXcel Therapeutics Price Rate Of Daily Change | 0.98 | |
| BioXcel Therapeutics Price Action Indicator | (0.04) | |
| BioXcel Therapeutics Price Daily Balance Of Power | (0.23) |
BioXcel Therapeutics July 19, 2025 Stock Price Analysis
BioXcel Stock Price History Data
The price series of BioXcel Therapeutics for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 0.87 with a coefficient of variation of 13.89. The prices are distributed with arithmetic mean of 1.7. The median price for the last 90 days is 1.74. The company had 1:16 stock split on 10th of February 2025.| Open | High | Low | Close | Volume | ||
| 07/18/2025 | 1.94 | 2.00 | 1.87 | 1.91 | 176,305 | |
07/17/2025 | 1.94 | 1.98 | 1.87 | 1.94 | 281,495 | |
07/16/2025 | 1.91 | 2.01 | 1.86 | 1.95 | 289,011 | |
| 07/15/2025 | 2.20 | 2.27 | 1.88 | 1.90 | 1,409,729 | |
07/14/2025 | 1.98 | 2.07 | 1.90 | 2.02 | 274,727 | |
07/11/2025 | 2.00 | 2.06 | 1.91 | 1.97 | 140,548 | |
07/10/2025 | 2.00 | 2.15 | 1.99 | 2.00 | 301,124 | |
07/09/2025 | 2.00 | 2.10 | 1.96 | 2.00 | 297,269 | |
07/08/2025 | 1.88 | 2.03 | 1.81 | 2.01 | 294,204 | |
07/07/2025 | 1.97 | 2.00 | 1.83 | 1.90 | 264,248 | |
| 07/03/2025 | 1.98 | 1.98 | 1.92 | 1.93 | 78,653 | |
07/02/2025 | 1.99 | 2.00 | 1.88 | 1.93 | 222,160 | |
| 07/01/2025 | 1.91 | 2.00 | 1.86 | 1.97 | 281,579 | |
| 06/30/2025 | 1.79 | 1.85 | 1.69 | 1.81 | 173,268 | |
06/27/2025 | 2.08 | 2.08 | 1.75 | 1.77 | 450,539 | |
06/26/2025 | 2.00 | 2.03 | 1.83 | 2.03 | 1,161,991 | |
| 06/25/2025 | 1.93 | 2.22 | 1.81 | 2.05 | 1,298,249 | |
06/24/2025 | 1.78 | 1.83 | 1.63 | 1.73 | 78,561 | |
| 06/23/2025 | 1.61 | 1.72 | 1.59 | 1.65 | 151,366 | |
06/20/2025 | 1.78 | 1.88 | 1.60 | 1.60 | 138,930 | |
| 06/18/2025 | 1.64 | 1.80 | 1.64 | 1.73 | 97,761 | |
06/17/2025 | 1.68 | 1.73 | 1.61 | 1.64 | 53,969 | |
| 06/16/2025 | 1.50 | 1.72 | 1.46 | 1.69 | 118,555 | |
| 06/13/2025 | 1.70 | 1.70 | 1.53 | 1.56 | 193,573 | |
06/12/2025 | 1.76 | 1.80 | 1.71 | 1.77 | 37,464 | |
06/11/2025 | 2.03 | 2.03 | 1.76 | 1.79 | 218,516 | |
06/10/2025 | 1.99 | 2.11 | 1.96 | 1.99 | 267,768 | |
06/09/2025 | 1.85 | 2.01 | 1.85 | 1.96 | 287,241 | |
06/06/2025 | 1.56 | 1.84 | 1.55 | 1.84 | 281,946 | |
06/05/2025 | 1.54 | 1.58 | 1.44 | 1.53 | 162,286 | |
06/04/2025 | 1.39 | 1.53 | 1.36 | 1.53 | 200,599 | |
06/03/2025 | 1.33 | 1.44 | 1.31 | 1.37 | 226,171 | |
06/02/2025 | 1.19 | 1.37 | 1.18 | 1.32 | 274,060 | |
| 05/30/2025 | 1.20 | 1.21 | 1.17 | 1.18 | 162,013 | |
05/29/2025 | 1.26 | 1.31 | 1.21 | 1.23 | 207,514 | |
05/28/2025 | 1.39 | 1.39 | 1.25 | 1.26 | 414,437 | |
| 05/27/2025 | 1.42 | 1.42 | 1.30 | 1.39 | 5,427,697 | |
05/23/2025 | 1.36 | 1.42 | 1.30 | 1.39 | 105,588 | |
05/22/2025 | 1.41 | 1.43 | 1.34 | 1.37 | 130,825 | |
05/21/2025 | 1.40 | 1.48 | 1.36 | 1.39 | 92,412 | |
05/20/2025 | 1.45 | 1.45 | 1.40 | 1.42 | 79,759 | |
05/19/2025 | 1.43 | 1.47 | 1.39 | 1.44 | 96,184 | |
05/16/2025 | 1.45 | 1.51 | 1.42 | 1.45 | 97,044 | |
05/15/2025 | 1.39 | 1.50 | 1.35 | 1.46 | 185,970 | |
05/14/2025 | 1.43 | 1.47 | 1.34 | 1.37 | 156,010 | |
05/13/2025 | 1.48 | 1.51 | 1.35 | 1.43 | 229,750 | |
05/12/2025 | 1.59 | 1.59 | 1.43 | 1.48 | 153,549 | |
05/09/2025 | 1.60 | 1.64 | 1.50 | 1.53 | 72,940 | |
05/08/2025 | 1.52 | 1.60 | 1.50 | 1.58 | 82,633 | |
05/07/2025 | 1.57 | 1.61 | 1.50 | 1.53 | 69,334 | |
| 05/06/2025 | 1.71 | 1.75 | 1.56 | 1.58 | 117,400 | |
05/05/2025 | 1.79 | 1.82 | 1.67 | 1.71 | 82,154 | |
05/02/2025 | 1.84 | 1.89 | 1.74 | 1.78 | 83,164 | |
05/01/2025 | 1.90 | 1.95 | 1.75 | 1.78 | 69,773 | |
04/30/2025 | 1.98 | 1.98 | 1.78 | 1.85 | 84,464 | |
04/29/2025 | 1.91 | 2.09 | 1.91 | 1.99 | 95,623 | |
04/28/2025 | 1.90 | 1.98 | 1.87 | 1.96 | 58,080 | |
04/25/2025 | 1.80 | 1.91 | 1.80 | 1.87 | 35,973 | |
04/24/2025 | 1.75 | 1.88 | 1.73 | 1.85 | 71,625 | |
04/23/2025 | 1.72 | 1.73 | 1.65 | 1.69 | 53,266 | |
04/22/2025 | 1.77 | 1.78 | 1.60 | 1.68 | 102,326 |
About BioXcel Therapeutics Stock history
BioXcel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioXcel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioXcel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioXcel Therapeutics stock prices may prove useful in developing a viable investing in BioXcel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.5 M | 2.4 M | |
| Net Loss | -149.2 M | -141.7 M |
BioXcel Therapeutics Quarterly Net Working Capital |
|
BioXcel Therapeutics Stock Technical Analysis
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
BioXcel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioXcel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of BioXcel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioXcel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0345 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.69) | |||
| Sortino Ratio | 0.0056 | |||
| Treynor Ratio | 0.1013 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |